Opioid Receptor Homo- and Heterodimerization in Living Cells by Quantitative Bioluminescence Resonance Energy Transfer

Opioid receptors have been shown to dimerize or oligomerize among themselves and each other, affecting their functional properties. This study used bioluminescence resonance energy transfer (BRET) between the μ, δ, and κ opioid receptors to study opioid receptor aggregation in transfected human embryonic kidney 293 cells. Titration of receptor levels indicated that all three opioid receptors have a similar affinity to form homo- or hetero-oligomers in combination with any other opioid receptor type. In contrast, none of the opioid receptors formed detectable oligomers with the muscarinic M2 receptor, indicating that interactions among opioid receptors are selective. The formation of opioid receptor dimers, rather than higher order oligomers, is supported by binding kinetics in competition experiments between labeled and unlabeled receptors. Opioid receptor dimerization occurred at physiological temperatures upon receptor biosynthesis, before trafficking to the plasma membrane. Moreover, using BRET, coimmunoprecipitation, receptor binding, and G protein coupling, we demonstrate for the first time functional μ opioid receptor-κ opioid receptor heterodimerization. These combined results demonstrate that opioid receptors can undergo homo- and heterodimerization, a process with potential implications for opioid physiology and pharmacology.

[1]  H. Saibil,et al.  Biophysics: is rhodopsin dimeric in native retinal rods? , 2003, Nature.

[2]  L. Devi,et al.  Heterodimerization of mu and delta opioid receptors: A role in opiate synergy. , 2000, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[3]  P. Fossier,et al.  Monitoring of Ligand-independent Dimerization and Ligand-induced Conformational Changes of Melatonin Receptors in Living Cells by Bioluminescence Resonance Energy Transfer* 210 , 2002, The Journal of Biological Chemistry.

[4]  L. Terenius,et al.  Dose- and Time-Dependent Bimodal Effects of κ-Opioid Agonists on Locomotor Activity in Mice , 2000 .

[5]  P. Uetz,et al.  Towards an understanding of complex protein networks. , 2001, Trends in cell biology.

[6]  Jamie Fong,et al.  Regulation of Opioid Receptor Trafficking and Morphine Tolerance by Receptor Oligomerization , 2002, Cell.

[7]  M. Gerstein,et al.  Thermostability of membrane protein helix–helix interaction elucidated by statistical analysis , 2002, FEBS letters.

[8]  S. Schulz,et al.  Homo- and Heterodimerization of Somatostatin Receptor Subtypes , 2001, The Journal of Biological Chemistry.

[9]  L. Devi,et al.  Dimerization of the delta opioid receptor: implication for a role in receptor internalization. , 1997, The Journal of biological chemistry.

[10]  Lakshmi A. Devi,et al.  Heterodimerization of μ and δ Opioid Receptors: A Role in Opiate Synergy , 2000, The Journal of Neuroscience.

[11]  B. O'dowd,et al.  Oligomerization of mu- and delta-opioid receptors. Generation of novel functional properties. , 2000, The Journal of biological chemistry.

[12]  M. Narita,et al.  Direct evidence for the up‐regulation of spinal µ‐opioid receptor function after repeated stimulation of κ‐opioid receptors in the mouse , 2003 .

[13]  E. Eliav,et al.  The kappa opioid agonist GR89 696 blocks hyperalgesia and allodynia in rat models of peripheral neuritis and neuropathy , 1999, PAIN.

[14]  Graeme Milligan,et al.  Homo- and hetero-oligomeric interactions between G-protein-coupled receptors in living cells monitored by two variants of bioluminescence resonance energy transfer (BRET): hetero-oligomers between receptor subtypes form more efficiently than between less closely related sequences. , 2002, The Biochemical journal.

[15]  A. Engel,et al.  Atomic-force microscopy: Rhodopsin dimers in native disc membranes , 2003, Nature.

[16]  A. Beaudet,et al.  Regulation of delta-opioid receptor trafficking via mu-opioid receptor stimulation: evidence from mu-opioid receptor knock-out mice. , 2003, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[17]  Jean-François Mercier,et al.  Quantitative Assessment of β1- and β2-Adrenergic Receptor Homo- and Heterodimerization by Bioluminescence Resonance Energy Transfer* , 2002, The Journal of Biological Chemistry.

[18]  I. Sora [Opioid receptor knockout mice]. , 1999, Nihon shinkei seishin yakurigaku zasshi = Japanese journal of psychopharmacology.

[19]  J. W. Wells,et al.  Monomers and oligomers of the M2 muscarinic cholinergic receptor purified from Sf9 cells. , 2003, Biochemistry.

[20]  P. Munson,et al.  Computer modeling of subtypes of κ opioid receptors in adrenal medulla , 1990 .

[21]  J. Raser,et al.  Control of Stochasticity in Eukaryotic Gene Expression , 2004, Science.

[22]  E. Lakatta,et al.  β1/β2-Adrenergic Receptor Heterodimerization Regulates β2-Adrenergic Receptor Internalization and ERK Signaling Efficacy* , 2002, The Journal of Biological Chemistry.

[23]  P. Law,et al.  Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[24]  Susan R. George,et al.  G-Protein-coupled receptor oligomerization and its potential for drug discovery , 2002, Nature Reviews Drug Discovery.

[25]  Lakshmi A. Devi,et al.  G-protein-coupled receptor heterodimerization modulates receptor function , 1999, Nature.

[26]  R. Dubner,et al.  Putative kappa-2 opioid agonists are antihyperalgesic in a rat model of inflammation. , 1997, The Journal of pharmacology and experimental therapeutics.

[27]  K. Blumer,et al.  G-protein-coupled receptors function as oligomers in vivo , 2000, Current Biology.

[28]  C. Stein,et al.  Characterization of μ Opioid Receptor Binding and G Protein Coupling in Rat Hypothalamus, Spinal Cord, and Primary Afferent Neurons during Inflammatory Pain , 2004, Journal of Pharmacology and Experimental Therapeutics.

[29]  D. Filliol,et al.  Analysis of [3H]bremazocine binding in single and combinatorial opioid receptor knockout mice. , 2001, European journal of pharmacology.

[30]  Michel Bouvier,et al.  Constitutive Agonist-independent CCR5 Oligomerization and Antibody-mediated Clustering Occurring at Physiological Levels of Receptors* 210 , 2002, The Journal of Biological Chemistry.

[31]  E. Lakatta,et al.  Beta 1/beta 2-adrenergic receptor heterodimerization regulates beta 2-adrenergic receptor internalization and ERK signaling efficacy. , 2002, The Journal of biological chemistry.

[32]  B. Mouillac,et al.  Oxytocin and vasopressin V1a and V2 receptors form constitutive homo- and heterodimers during biosynthesis. , 2003, Molecular endocrinology.

[33]  L. Vogt,et al.  κ Opioid Receptor Stimulation of [35S] GTPγS Binding in Guinea Pig Brain , 1998 .

[34]  S. Rees,et al.  Monitoring Receptor Oligomerization Using Time-resolved Fluorescence Resonance Energy Transfer and Bioluminescence Resonance Energy Transfer , 2001, The Journal of Biological Chemistry.

[35]  M. Iadarola,et al.  GR89,696 is a kappa-2 opioid receptor agonist and a kappa-1 opioid receptor antagonist in the guinea pig hippocampus. , 1997, The Journal of pharmacology and experimental therapeutics.

[36]  Jean-François Mercier,et al.  Quantitative assessment of beta 1- and beta 2-adrenergic receptor homo- and heterodimerization by bioluminescence resonance energy transfer. , 2002, The Journal of biological chemistry.

[37]  Michel Bouvier,et al.  A Peptide Derived from a β2-Adrenergic Receptor Transmembrane Domain Inhibits Both Receptor Dimerization and Activation* , 1996, The Journal of Biological Chemistry.

[38]  H. Szeto,et al.  Comparison of [Dmt1]DALDA and DAMGO in Binding and G Protein Activation at μ, δ, and κ Opioid Receptors , 2003, Journal of Pharmacology and Experimental Therapeutics.

[39]  J. Bidlack,et al.  Kappa-opioid receptors on lymphocytes of a human lymphocytic cell line: morphine-induced up-regulation as evidenced by competitive RT-PCR and indirect immunofluorescence. , 2001, International immunopharmacology.

[40]  A. Beaudet,et al.  Regulation of δ-Opioid Receptor Trafficking via μ-Opioid Receptor Stimulation: Evidence from μ-Opioid Receptor Knock-Out Mice , 2003, The Journal of Neuroscience.

[41]  C. Fowler,et al.  μ-, δ-, κ-Opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments , 1994, Neurochemistry International.

[42]  H. Saibil,et al.  Arachnology: Scavenging by brown recluse spiders , 2003, Nature.

[43]  Lakshmi A Devi,et al.  A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Marta Filizola,et al.  Structural models for dimerization of G-protein coupled receptors: the opioid receptor homodimers. , 2002, Biopolymers.

[45]  S. Angers,et al.  Detection of beta 2-adrenergic receptor dimerization in living cells using bioluminescence resonance energy transfer (BRET). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[46]  Marta Filizola,et al.  Prediction of heterodimerization interfaces of G-protein coupled receptors with a new subtractive correlated mutation method. , 2002, Protein engineering.

[47]  Lakshmi A. Devi,et al.  A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia , 2004 .

[48]  Jean-François Mercier,et al.  Homodimerization of the β2-Adrenergic Receptor as a Prerequisite for Cell Surface Targeting* , 2004, Journal of Biological Chemistry.

[49]  Michel Bouvier,et al.  Oligomerization of G-protein-coupled transmitter receptors , 2001, Nature Reviews Neuroscience.